Lucera Erick, CFO of Dyne Therapeutics DYN, has filed 2 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $181.5K. The latest trade was on 06/25.

LE

LE

Lucera Erick

CFO

Company

Dyne Therapeutics DYN

First filing

23/01/19

Trades

59 trades

Buys / sales

2 / 5

12-month net buying

−$181.5K

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dyne TherapeuticsDYN	Open-market sale	06/25	06/26	2,362 sh	$20.37	$48,113.94	−1.9%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	05/13	05/14	1,448 sh	$18.36	$26,585.28	−1.2%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	04/01	04/03	5,727 sh	$18.64	$106,751.28	−4.4%
Editas MedicineEDIT	Open-market sale10b5-1 plan	25/03/04	25/03/05	4,109 sh	$1.71	$7,026.39	−3.5%
Beyond AirXAIR	Open-market buy	24/08/14	24/08/15	39,266 sh	$0.40	$15,706.4	+904.3%
Editas MedicineEDIT	Open-market sale10b5-1 plan	24/05/20	24/05/22	22,337 sh	$5.61	$125,310.57	−16.1%
Beyond AirXAIR	Open-market buy	23/03/16	23/03/20	2,000 sh	$6.82	$13,640	+85.4%